By Chris Wack Heron Therapeutics shares were up 15% to $2.53 after the U.S. Food and Drug Administration approved its supplemental new drug application for.
By Will Feuer Shares of Verrica Pharmaceuticals climbed after its development and commercialization partner, Torii Pharmaceutical, reported positive top-line.
By Dean Seal Shares of Avita Medical fell after the company lowered its revenue guidance for 2023. The stock was down 13% at $10.91 in premarket trading..
By Dean Seal Shares of Avita Medical soared after the company logged a smaller loss and slightly higher revenue in the third quarter than analysts had been.
By Ben Glickman Bausch Health Cos. has received approval from the Food and Drug Administration for Cabtreo, its topical gel for acne. The Laval, Quebec-based.